期刊文献+

真皮纤维瘤和隆突性皮肤纤维肉瘤分子表型差异及组织起源探讨 被引量:5

Differences of the molecular phenotypes and the histogenesis between dermatofibroma and dermatofibrosarcoma protuberans
下载PDF
导出
摘要 目的:探讨真皮纤维瘤(dermatofibroma,DF)和隆突性皮肤纤维肉瘤(dermatofibrosarcoma protuberans,DFSP)的组织起源和分化。方法:选取DF和DFSP各26例,收集详细临床资料,分析两组的组织病理形态;采用组织芯片对全部病例进行免疫组织化学染色分析,抗体为Factor ⅩⅢa,HLA-DR,CD34,CD14,S-100,MSA和Ki67;用体外转录法制备转化生长因子(transforming growth factor β,TGF-β)和碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF)探针;用原位杂交法检测TGF-β和bFGF在肿瘤中的表达。结果:全部病例均不同程度表达FactorⅩⅢa,HLA-DR和CD34。三者阳性细胞率的中位数在26例DF中分别为:FactorⅩⅢa为90%,HLA-DR为70%,CD34为5%。三者阳性细胞率的中位数在26例DFSP中分别为:FactorⅩⅢa为10%,HLA-DR为5%,CD34为80%。3例DF和1例DFSP有少数细胞CD14阳性。2例DF和6例DFSP有少数细胞S-100阳性。3例DF和5例DFSP有极少数细胞MSA阳性。全部病例Ki67阳性细胞率小于5%。原位杂交检测结果:TGF-β在DF中的表达强度高于DFSP。结论:DF和DFSP不同程度表达树突状细胞(dendritic cell,DC)谱系特征,DF在组织形态和免疫表型上更趋向表达成熟DC特征,支持该肿瘤良性的生物学行为;而DFSP趋向显示不成熟的真皮储备细胞(dermal reserve cell,DRC)特征,与该肿瘤低度恶性生物学行为相符;某些肿瘤两种抗体表达的阳性细胞率呈中间状态;有关FactorⅩⅢa和CD34表达差异的认识和运用有助于肿瘤的诊断和鉴别诊断。 Objective:To explore the histogenesis and differentiation of dermatofibroma (DF) and dermatofibrosarcoma protuberans (DFSP). Methods: Clinical information and microscopic characteristics of 26 cases of DF and 26 cases of DFSP were investigated. The immunohistochemical study was performed on microarray sections by a panel of antibodies including FactorⅫa, HLA-DR, CD34, CD14, S-100, MSA, and Ki67. Probe was labeled by in vitro transcription. The mRNA expression levels of TGF-β and bFGF were investigated by in situ hybridization. Results: All cases showed positive for Factor Ⅻa, HLA- DR and CD34 to different extent. The medians of positive rates in DF were FactorⅫa 90% , HLA-DR 70% , and CD34 5% , and in DFSP were FactorⅫa 10% , HLA-DR 5% , and CD34 80%. CD14 was positive in 3 cases of DF and 1 case of DFSP. S-100 was positive in 6 cases of DFSP and 2 cases of DF. MSA was positive in 5 cases of DFSP and 3 cases of DF. In all cases, positive rate of Ki67 was less than 5%. The mRNA expression levels of TGF-β was elevated in DF in comparison with DFSP. Conclusion: Both DF and DFSP can differentiate to dendritic cells (DC) in different degree. Considering the character of microscopic features and immunohistochemical phenotype, cells of DF are much similar to mature DC, while those of DFSP much similar to immature dermal reserve cell (DRC). The differences of cell differentiation between DF and DFSP result in different prognosis. DF is a benign tumor, while DFSP a low grade malignant tumor. The different expression of FactorⅫa and CD34 may be helpful to differential diagnosis of DF and DFSP.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2008年第4期395-400,共6页 Journal of Peking University:Health Sciences
关键词 组织细胞瘤 良性纤维性 皮肤纤维肉瘤 因子ⅩⅢa 抗原 CD34 转化生长因子Β Histiocytoma, benign fibrous Dermatofibrosarcoma Factor Ⅷ a Antigens, CD34 Transforming growth factor beta
  • 相关文献

参考文献17

  • 1Dowd JO, Laddle P. Progression of dermatofibrosarcoma protuberans to malignant fibrous histiocytoma: report of a case with implications of tumor histogenesis [J]. Hum Pathol, 1998, 19 : 368 - 370.
  • 2Lautier R, Wolff HH, Jones RE. An immunocytochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic component [ J]. Am J Dermatopathol, 1990, 12:25 -30.
  • 3Silverman JS, Glusac EJ. Epithelioid cell histiocytoma-histogenetic and kinetics analysis of dermal microvascular unit dendritic cell subpopulations [J]. J Cutan Pathol, 2003, 30:415 -422.
  • 4Cerio R, Spaull J, Jones EW. Histiocytoma cutis: a tumor of dermal dendrocytes (dermal dendrocytoma) [ J ]. Br J Dermatol, 1989, 120:197-206.
  • 5Silverraan JS, Tamsen A. Interactive CD34^+ fibroblasts and factor ⅩⅢa-positive histiocytes in cutaneous mesenchymal tumors[ J]. Am J Dermatopathol, 1998, 20:317 -320.
  • 6熊焰,郭华,李挺.树突状细胞与几种纤维性肿瘤关系的研究进展[J].诊断病理学杂志,2008,15(4):330-332. 被引量:1
  • 7Lu Dongqing, Sueki H, lijima M. Number and distribution of interstitial cells lining the epidermis of normal human skin from different anatomical locations [ J]. Eur J Dermatol, 2002, 12: 149 - 153.
  • 8Derrick EK, Barker JNWN, Khan A, et al. The tissue distribution of Factor ⅩⅢa positive ceil [J]. Histopathology, 1993,22:157 - 162.
  • 9Daniel N,Jean K, Michel F , et al. Immunohistochemical study of CD34-positive dendritic cells of human dennis [J]. Am J Dermatol, 1996, 18:283-288.
  • 10Mollah ZUA, Aiba S, Manome H, et al. Cord blood CD34 + cells differentiate into dermal dendritic cells in co-culture with cutaneous fibroblasts or stromal cells [ J ]. J Invest Dermatol, 2002, 118:450-460.

二级参考文献39

  • 1Amaud E, Touriol C, Gensac MC, et al. A new 34-kilo Dalton isoform of fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol, 1999,191(1):505-514.
  • 2Shen B, Arese M, Gualandris A, et al.Intracellular association of FGF2 with the ribosomal protein L6/TAXREB107. Biochem Biophys Res Comnun, 1998,252(2):524-528
  • 3Wilkie AO, Patey SJ, Kan SH. FGFs, their receptors,and human limb malformations:clinical and molecular correlations. Am J Med Genet,2002,112(3):266-278.
  • 4Okada-Ban M, Thiery JP, Jouanneau J. Fibroblast growth factor-2.Int J Biochem Cell Biol, 2000,32(3):263-267.
  • 5Patry V, Arnaud E, Amalric F, et al.Involvement of basic fihroblast growth factor NH2 terminus in the nuclear accumulation. Growth factors, 1994,11(3):163-174.
  • 6Ornitz DM. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays, 2000,22(2):108-112.
  • 7Klagsbrun M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell, 1991,67(2):229-231.
  • 8Thomas KA. Fibroblast growth factor. FASEB J,1987,1(6):434-440.
  • 9Renko M, Quarto N, Morimoto T, et al. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol, 1990,144(1):108-114.
  • 10Amalric F, Baldin V, Bosc-Bierne I, et al. Nuclear translocation of basic fibroblast growth factor. Ann N Y Acad Sci,1991,638:127-138.

共引文献21

同被引文献36

  • 1丁康,张鋆歆.高频超声诊断隆突性皮肤纤维肉瘤一例[J].中华医学超声杂志(电子版),2006,3(4). 被引量:3
  • 2李琳,姜颖.隆突性皮肤纤维肉瘤超声表现1例[J].中华超声影像学杂志,2006,15(5):353-353. 被引量:2
  • 3林上奇,鲁西,吴宝珊.颈部隆突性皮肤纤维肉瘤二例[J].中华放射学杂志,1996,30(10):716-716. 被引量:2
  • 4Zamecnik M,Michal M.ELLA + cells in dermatofibrosarcoma Protuberans:a study of 11 tumors suggesting perineurial cell differentiation[J].Cesk Patol,2002,38(2):55-62.
  • 5Stojadinovic A,Karpoff HM,Antonescu CR,et al.Dermatofibrosarcoma protuberans of the head and neck[J].Ann Surgoncol,2000,7(9):696-704.
  • 6Bames L,Coleman JA,Johnson JT.Dermatofibrosarcoma protuberans of the head and neck[J].Arch Otolaryngol Head Neck Surg,1984,110(6):398-404.
  • 7Zhao M,PipeJG,Bonnett J,et al.Early detection of treatment reseponse by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo[J].Br J Cancer,1996,73(1):61-64.
  • 8Kransdorf MJ,Meis-Kindblom JM.Dermatofibrosarcoma protuberans:radiologic appearance[J].AJR,1994,163(2):391-394.
  • 9Torreggiani WC,Al-ismail K,Munk PL,et al.Dermatofibrosarcoma protuberans:MR imaging features[J].AJR,2002,178(4):989-993.
  • 10Kamiya T, Saga K, Kaneko R, et al. Postradiation dermatofi- brosarcoma protuberans. Acta Derm Venereol, 2006, 86 (2): 152-153.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部